Matches in Nanopublications for { ?s ?p "[The present data demonstrate that the privileged nonpeptide P2 ligand, bis-THF, is critical for the binding of GRL-98065 to the HIV protease substrate binding site and that this scaffold can confer highly potent antiviral activity against a wide spectrum of HIV isolates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP434902.RAez6uKiNhFPKmKVRUqGQZwJEfNaPXrhUsShEae456UwM130_assertion description "[The present data demonstrate that the privileged nonpeptide P2 ligand, bis-THF, is critical for the binding of GRL-98065 to the HIV protease substrate binding site and that this scaffold can confer highly potent antiviral activity against a wide spectrum of HIV isolates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434902.RAez6uKiNhFPKmKVRUqGQZwJEfNaPXrhUsShEae456UwM130_provenance.
- NP873854.RASy_5reXTtWt0z9ZnwFwdLokB9m-nA6aDAdTd3dcgwDc130_assertion description "[The present data demonstrate that the privileged nonpeptide P2 ligand, bis-THF, is critical for the binding of GRL-98065 to the HIV protease substrate binding site and that this scaffold can confer highly potent antiviral activity against a wide spectrum of HIV isolates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873854.RASy_5reXTtWt0z9ZnwFwdLokB9m-nA6aDAdTd3dcgwDc130_provenance.
- NP599825.RAJe-vyDD-4QsegyMzmvq-EiyuYVMEpiI9mUX01tSpYcw130_assertion description "[The present data demonstrate that the privileged nonpeptide P2 ligand, bis-THF, is critical for the binding of GRL-98065 to the HIV protease substrate binding site and that this scaffold can confer highly potent antiviral activity against a wide spectrum of HIV isolates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599825.RAJe-vyDD-4QsegyMzmvq-EiyuYVMEpiI9mUX01tSpYcw130_provenance.
- NP599826.RAOSmzxVVuGPZRHpOcE3NSSF3zTddGoI_bJuq0N-fvVPU130_assertion description "[The present data demonstrate that the privileged nonpeptide P2 ligand, bis-THF, is critical for the binding of GRL-98065 to the HIV protease substrate binding site and that this scaffold can confer highly potent antiviral activity against a wide spectrum of HIV isolates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599826.RAOSmzxVVuGPZRHpOcE3NSSF3zTddGoI_bJuq0N-fvVPU130_provenance.